title: Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems.
abstract: Our objective was to examine the evidence of in vitro synergy of polymyxin-carbapenem combination therapy against Gram-negative bacteria (GNB). A systematic review and meta-analysis were performed. All studies examining in vitro interactions of antibiotic combinations consisting of any carbapenem with colistin or polymyxin B against any GNB were used. A broad search was conducted with no language, date, or publication status restrictions. Synergy rates, defined as a fractional inhibitory concentration index of ≤0.5 or a >2-log reduction in CFU, were pooled separately for time-kill, checkerboard, and Etest methods in a mixed-effect meta-analysis of rates. We examined whether the synergy rate depended on the testing method, type of antibiotic, bacteria, and resistance to carbapenems. Pooled rates with 95% confidence intervals (CI) are shown. Thirty-nine published studies and 15 conference proceeding were included, reporting on 246 different tests on 1,054 bacterial isolates. In time-kill studies, combination therapy showed synergy rates of 77% (95% CI, 64 to 87%) for Acinetobacter baumannii, 44% (95% CI, 30 to 59%) for Klebsiella pneumoniae, and 50% (95% CI, 30 to 69%) for Pseudomonas aeruginosa, with low antagonism rates for all. Doripenem showed high synergy rates for all three bacteria. For A. baumannii, meropenem was more synergistic than imipenem, whereas for P. aeruginosa the opposite was true. Checkerboard and Etest studies generally reported lower synergy rates than time-kill studies. The use of combination therapy led to less resistance development in vitro. The combination of a carbapenem with a polymyxin against GNB, especially A. baumannii, is supported in vitro by high synergy rates, with low antagonism and less resistance development. These findings should be examined in clinical studies.
authors.affiliation: Department of Medicine E, Rabin Medical Center, Petah-Tiqva, Israel.
authors.forename: Oren
authors.initials: O
authors.lastname: Zusman
authors.forename: Tomer
authors.initials: T
authors.lastname: Avni
authors.forename: Leonard
authors.initials: L
authors.lastname: Leibovici
authors.forename: Amos
authors.initials: A
authors.lastname: Adler
authors.forename: Lena
authors.initials: L
authors.lastname: Friberg
authors.forename: Theodouli
authors.initials: T
authors.lastname: Stergiopoulou
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Carmeli
authors.forename: Mical
authors.initials: M
authors.lastname: Paul
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015780:Carbapenems / Q000494:pharmacology*; D004357:Drug Synergism; D008826:Microbial Sensitivity Tests; D011113:Polymyxins / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D011113:Polymyxins
references.citation: Antimicrob Agents Chemother. 2011 Dec;55(12):5685-95
references.pmid: 21911563
references.citation: Int J Antimicrob Agents. 2007 Dec;30(6):537-40
references.pmid: 17851050
references.citation: Clin Microbiol Infect. 1999 Jan;5(1):32-36
references.pmid: 11856210
references.citation: J Med Microbiol. 2012 Mar;61(Pt 3):353-360
references.pmid: 22016557
references.citation: Clin Infect Dis. 2005 May 1;40(9):1333-41
references.pmid: 15825037
references.citation: Diagn Microbiol Infect Dis. 2011 Jun;70(2):246-52
references.pmid: 21353436
references.citation: J Med Assoc Thai. 2010 Feb;93(2):161-71
references.pmid: 20301995
references.citation: Diagn Microbiol Infect Dis. 2009 Feb;63(2):228-32
references.pmid: 19150711
references.citation: J Clin Microbiol. 2010 Oct;48(10):3558-62
references.pmid: 20686085
references.citation: Minerva Anestesiol. 2008 Jan-Feb;74(1-2):47-9
references.pmid: 18059255
references.citation: J Microbiol Immunol Infect. 2010 Aug;43(4):317-22
references.pmid: 20688292
references.citation: Clin Infect Dis. 2005 Jul 15;41(2):149-58
references.pmid: 15983909
references.citation: Antimicrob Agents Chemother. 2011 Nov;55(11):5134-42
references.pmid: 21876058
references.citation: Diagn Microbiol Infect Dis. 2011 Jul;70(3):380-6
references.pmid: 21558048
references.citation: Diagn Microbiol Infect Dis. 2011 Aug;70(4):561-4
references.pmid: 21767715
references.citation: BMC Infect Dis. 2011 Apr 27;11:109
references.pmid: 21521536
references.citation: Clin Microbiol Infect. 2012 Jan;18(1):30-9
references.pmid: 21988234
references.citation: J Antimicrob Chemother. 2005 Jun;55(6):954-7
references.pmid: 15883174
references.citation: J Antimicrob Chemother. 2010 May;65(5):1019-27
references.pmid: 20299494
references.citation: J Clin Med Res. 2013 Apr;5(2):97-100
references.pmid: 23519391
references.citation: Euro Surveill. 2008 Nov 20;13(47):
references.pmid: 19021957
references.citation: Chemotherapy. 2008;54(2):147-51
references.pmid: 18322363
references.citation: Minerva Anestesiol. 2007 Mar;73(3):181-5
references.pmid: 17159765
references.citation: Antimicrob Agents Chemother. 2008 Jan;52(1):333-6
references.pmid: 17967915
references.citation: Antimicrob Agents Chemother. 2010 Nov;54(11):4678-83
references.pmid: 20713678
references.citation: Crit Care. 2006 Feb;10(1):R27
references.pmid: 16507149
references.citation: Antimicrob Agents Chemother. 2010 Jun;54(6):2732-4
references.pmid: 20368401
references.citation: Diagn Microbiol Infect Dis. 2010 Jun;67(2):191-7
references.pmid: 20338710
references.citation: Clin Microbiol Infect. 2008 Sep;14(9):816-27
references.pmid: 18844682
references.citation: Antimicrob Agents Chemother. 2012 Oct;56(10):5103-12
references.pmid: 22802247
references.citation: Diagn Microbiol Infect Dis. 1987 Feb;6(2):157-64
references.pmid: 3102156
references.citation: BMJ. 2003 May 24;326(7399):1111
references.pmid: 12763980
references.citation: J Infect Dev Ctries. 2010 Mar 29;4(3):164-7
references.pmid: 20351457
references.citation: BMJ. 2004 Mar 20;328(7441):668
references.pmid: 14996699
references.citation: Int J Antimicrob Agents. 2011 Jun;37(6):491-503
references.pmid: 21292449
references.citation: Int J Antimicrob Agents. 2006 Mar;27(3):224-8
references.pmid: 16464562
references.citation: Antimicrob Agents Chemother. 2009 May;53(5):2133-5
references.pmid: 19258266
references.citation: J Antimicrob Chemother. 2010 Jan;65(1):82-90
references.pmid: 19861334
references.citation: J Antimicrob Chemother. 2005 Jul;56(1):128-32
references.pmid: 15917285
references.citation: Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):890-900
references.pmid: 22299471
references.citation: Ann Clin Microbiol Antimicrob. 2006 Apr 21;5:10
references.pmid: 16630352
references.citation: Scand J Infect Dis. 2006;38(4):268-72
references.pmid: 16709527
references.citation: Antimicrob Agents Chemother. 2007 Sep;51(9):3413-5
references.pmid: 17620384
references.citation: Antimicrob Agents Chemother. 2012 Jun;56(6):3395-8
references.pmid: 22430958
references.citation: Antimicrob Agents Chemother. 2004 Mar;48(3):753-7
references.pmid: 14982760
references.citation: Diagn Microbiol Infect Dis. 2012 Dec;74(4):417-9
references.pmid: 22995366
references.citation: J Chemother. 2008 Apr;20(2):180-5
references.pmid: 18467243
references.citation: Clin Microbiol Infect. 2012 Jan;18(1):18-29
references.pmid: 22168320
references.citation: Antimicrob Agents Chemother. 2007 Jun;51(6):2005-10
references.pmid: 17403995
references.citation: PLoS One. 2011;6(12):e28177
references.pmid: 22162759